About the forum

The purpose of RDAF is to serve as a platform to exchange ideas and define actions to raise awareness of rare diseases and to improve access to treatment and patient care in Switzerland.


RDAF brings together experts from various stakeholders in the field of rare diseases.



Latest News

News - 24 September 2018
RDAF event
Value assessment for orphan drugs in Switzerland and the EU
31 October 2018, Basel

Join us for this international event organized by the Rare Disease Action Forum (RDAF). Meet experts from national competent authorities, industry and patient organizations. Exchange knowledge on value assessment for orphan drugs from different European countries including Switzerland, Germany, Austria and France.

Final Program                                     Registration


News - 23 July 2018
New member joined the RDAF in July 2018

In July 2018, Roche joined the Rare Disease Action Forum (RDAF), which now hosts a total of 16 members. With its increased membership, the RDAF reinforces its contribution towards the development of sustainable solutions to improve the situation of patients with rare diseases in Switzerland.